Catalyst Wire Dossier Catalyst Wire Dossier

Ibutamoren

ibutamoren
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibutamoren, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease [Phase 2]

See pricing